Today we focus on the challenges and success stories of HPV vaccine uptake, specifically in Italy and Australia. The HPV vaccine rollout has translated into a significant reduction in the prevalence of cervical and anal cancers. Since its discovery, many different strategies have been used to increase and maintain its uptake in school children, both girls and boys.
STI's Podcast Editor, Dr Fabiola Martin, interviews Prof Anna Maria Garretti, Diseases at the Policlinico Tor Vergata, University of...
Today we focus on the challenges and success stories of HPV vaccine uptake, specifically in Italy and Australia. The HPV vaccine rollout has translated into a significant reduction in the prevalence of cervical and anal cancers. Since its discovery, many different strategies have been used to increase and maintain its uptake in school children, both girls and boys.
STI's Podcast Editor, Dr Fabiola Martin, interviews Prof Anna Maria Garretti, Diseases at the Policlinico Tor Vergata, University of Rome Tor Vergata, Chair of the British HIV Association Vaccination Guidelines Panel, and Editor in Chief of the STI Journal; Prof Carlo Giaquinto, Director of the Paediatric Infectious Diseases Unit at the Department of Woman's and Child's Health of the University of Padova Prof; and Ian Frazer, Clinical immunologist and scientist, The University of Queensland Diamantina Institute, Brisbane, Australia.
Read the related blog post: https://blogs.bmj.com/sti/2021/06/04/hpv-vaccine-uptake-achievements-and-challenges/
Related content from STI:
https://sti.bmj.com/content/early/2020/09/02/sextrans-2020-054428
https://sti.bmj.com/content/95/5/386
https://sti.bmj.com/content/95/8/608
https://sti.bmj.com/content/early/2020/12/23/sextrans-2020-054726
